What is the official ID of this bill?

The official print number for this legislation is HR 6834.

When did the legislative process begin?

The process officially started on 2022-02-25.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/117/bills/hr6834/BILLS-117hr6834ih.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

Who is the primary sponsor?

The primary sponsor is Rep. DeLauro, Rosa L. [D-CT-3].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Analysis and Potential Impact of HR 6834

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Mandatory Recall of Unsafe Drugs: Enhanced Patient Safety

Q: What are the main provisions?

Key points include: Increased authority for officials to order immediate recall of dangerous drugs from the market. Pharmaceutical companies must report drugs that may pose a serious threat to health or life. Requirement for companies to have drug recall plans in place. Ability to quickly appeal a drug recall order, but the recall must proceed during the appeal.

New rules grant officials greater power to order the recall of drugs that may be harmful to health or life. Pharmaceutical companies will need to report drug problems faster and have recall plans in place. This aims to increase the safety of medicines available to citizens.

Key points

Increased authority for officials to order immediate recall of dangerous drugs from the market.

Pharmaceutical companies must report drugs that may pose a serious threat to health or life.

Requirement for companies to have drug recall plans in place.

Ability to quickly appeal a drug recall order, but the recall must proceed during the appeal.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

Recall Unsafe Drugs Act of 2022

Print number: HR 6834

Sponsor: Rep. DeLauro, Rosa L. [D-CT-3]

Process start date: 2022-02-25

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-05-20

Source data: api.congress.gov

AI work logs for this document launch

Mandatory Recall of Unsafe Drugs: Enhanced Patient Safety

Key Questions about Mandatory Recall of Unsafe Drugs: Enhanced Patient Safety